Astex Pharmaceuticals, Inc. (ASTX)
-NasdaqGS | Prev Close: | 5.12 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | 5.62 x 7400 |
|---|
| 1y Target Est: | 7.33 |
|---|
| Beta: | 1.65 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.64 - 6.95 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,769,140 |
|---|
| Market Cap: | 484.37M |
|---|
| P/E (ttm): | 106.67 |
|---|
| EPS (ttm): | 0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Astex Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Mon, May 20)
- ASTEX PHARMACEUTICALS, INC FinancialsEDGAR Online Financials(Fri, May 17)
- Astex Pharmaceuticals to Present at UBS Global Healthcare ConferenceGlobeNewswire(Tue, May 14)
- Short Interest Moves 16% Higher For ASTXat TheStreet(Fri, May 10)
- ASTEX PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Sat, May 4)
- Astex Pharmaceuticals Inc Stock Downgraded (ASTX)at TheStreet(Wed, May 1)
- Expert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell OverseasWall Street Transcript(Tue, Apr 30)
- Astex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Apr 29)
- BRIEF-Astex Pharmaceuticals shares up 1 pct after the bell following resultsat Reuters(Mon, Apr 29)
- Astex Pharmaceuticals Reports 2013 First Quarter Financial ResultsGlobeNewswire(Mon, Apr 29)
- ASTEX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online(Mon, Apr 29)
- Q1 2013 Astex Pharmaceuticals Inc Earnings Release - After Market CloseCCBN(Mon, Apr 29)
- 5 Reasons to Worry About Next Weekat Motley Fool(Fri, Apr 26)
- Astex Pharmaceuticals to Present at Needham Healthcare ConferenceGlobeNewswire(Tue, Apr 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 5.82 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.29 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.06 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid.
View More